Suppr超能文献

基于互联网的宫颈癌筛查中人乳头瘤病毒自我采样检测的有效性和可行性。

Effectiveness and feasibility of self-sampling for human papillomavirus testing for internet-based cervical cancer screening.

机构信息

Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, China.

Department of Obstetrics and Gynecology, Peking University Shenzhen Hospital, Shenzhen, China.

出版信息

Front Public Health. 2022 Nov 7;10:938272. doi: 10.3389/fpubh.2022.938272. eCollection 2022.

Abstract

OBJECTIVES

Worldwide, around 18.2% of cervical cancer occurred in China, mainly because of lower screening coverage and screening quality in regional disparities. To assess self-sampling for human papillomavirus (HPV) testing, combined with the internet, as a primary cervical cancer screening (CCS) method in low-resource settings, and to establish an internet-based self-sampling CCS-management model.

METHODS

The women who participated registered on a CCS website. We recruited 20,136 women, aged 30-59 years, from 13 provinces in China, to perform vaginal self-sampling for HPV testing as a primary CCS, based on the internet. A questionnaire was subsequently used to investigate the acceptability of self-sampling.

RESULTS

Of the 20,103 women with qualified samples, 35.80% lived in remote areas, 37.69% had never undergone CCS, 59.96% were under-screened, and the overall prevalence of a high-risk of HPV was 13.86%. Of 8,136 respondents, 95.97% of women felt that self-sampling was easy to perform, 84.61% had no discomfort when using a self-sampling brush, 62.37% women were more likely to choose self-sampling for CCS in future, and 92.53% were willing to introduce the concept to others around them. The reliability and ease of self-sampling were independent factors influencing selection of self-sampling ( < 0.05).

CONCLUSIONS

The Internet-facilitated self-sampling for HPV testing and management model for cervical cancer prevention is feasible and effective. It can be used as a supplement to the conventional screening, particularly in outlying areas with few medical resources, to improve the coverage of CCS.

CLINICAL TRIAL REGISTRATION

https://www.chictr.org.cn, identifier: ChiCTR2000032331.

摘要

目的

全世界范围内,约 18.2%的宫颈癌发生在中国,主要是因为在地域差异下,筛查覆盖率和筛查质量较低。本研究旨在评估互联网辅助下的人乳头瘤病毒(HPV)自我采样作为一种在资源匮乏地区进行宫颈癌初筛(CCS)的方法,并建立一种基于互联网的自我采样 CCS 管理模式。

方法

参与的妇女在 CCS 网站上注册。我们从中国 13 个省份招募了 20136 名年龄在 30-59 岁的妇女,通过互联网对其进行 HPV 自我采样检测,作为初筛方法。随后使用问卷对自我采样的可接受性进行调查。

结果

在 20103 名有合格样本的妇女中,35.80%来自偏远地区,37.69%从未接受过 CCS,59.96%为未筛查人群,高危型 HPV 总患病率为 13.86%。在 8136 名受访者中,95.97%的女性认为自我采样易于实施,84.61%在使用采样刷时没有不适感,62.37%的女性在未来更倾向于选择自我采样进行 CCS,92.53%的女性愿意向周围人介绍这一概念。自我采样的可靠性和易用性是影响自我采样选择的独立因素(<0.05)。

结论

互联网辅助 HPV 自我采样和宫颈癌防治管理模式是可行且有效的。它可以作为传统筛查的补充,特别是在医疗资源匮乏的偏远地区,以提高 CCS 的覆盖率。

临床试验注册

https://www.chictr.org.cn,标识符:ChiCTR2000032331。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e19f/9677822/f6126451b291/fpubh-10-938272-g0001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验